viral persistence

  1. Chandelier

    Preprint Multiomic and Spatial Profiling of Colorectal Tissue Reveals Viral Persistence and Immune Dysregulation in Long COVID, 2026, LaFranchi et al.

    Multiomic and Spatial Profiling of Colorectal Tissue Reveals Viral Persistence and Immune Dysregulation in Long COVID Abstract Long COVID (LC) - a chronic condition characterized by persistent, debilitating symptoms following SARS-CoV-2 infection - has emerged as a major public health...
  2. SNT Gatchaman

    Virus reactivation in acute and long COVID-19, 2026, Maguire et al

    Now published, see post #6. Preprint: Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19 Chronic viral infections are ubiquitous in humans, with individuals harboring multiple latent viruses that can...
  3. Chandelier

    Case Report: Post-Mortem Analysis of Long-Term Inflammation After Mild COVID-19, 2026, Wu et al.

    Case Report: Post-Mortem Analysis of Long-Term Inflammation After Mild COVID-19 Abstract Persistent inflammation and tissue injury may contribute to post-acute COVID-19 syndrome (PACS). However, direct tissue evidence from mildly-infected individuals sampled long after recovery remains...
  4. SNT Gatchaman

    Longitudinal assessment of SARS-CoV-2 Spike and Nucleocapsid antigenemia in the ORCHESTRA Post-COVID cohort, 2026, Coppens et al.

    Longitudinal assessment of SARS-CoV-2 Spike and Nucleocapsid antigenemia in the ORCHESTRA Post-COVID cohort OBJECTIVES Spike antigenemia has been proposed as a mechanism underlying post-COVID condition (PCC). We determined whether persistent free SARS-CoV-2 Spike or Nucleocapsid antigenemia is...
  5. Chandelier

    Review Implications of RNA virus persistence for post-acute sequelae and chronic inflammatory syndromes, 2026, Vidal et al.

    Implications of RNA virus persistence for post-acute sequelae and chronic inflammatory syndromes Vidal, Daniela; Castro, Ítalo de Araújo; López, Carolina B. Abstract Viral persistence refers to the ability of a virus to remain in its host for an extended period. Although most non-retroviral...
  6. SNT Gatchaman

    Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID, 2026, Mateu et al.

    Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID OBJECTIVES SARS-CoV-2 antigens have been detected in plasma months after acute infection, but their long-term dynamics and clinical relevance remain unclear. We aimed to assess the persistence and clinical...
  7. F

    Preprint Single-cell profiling of innate and adaptive immune dysregulation in Long COVID, 2026, Satpathy et al.

    Abstract The COVID-19 pandemic has infected more than 778 million people worldwide. Roughly 7% of these patients progress to Long COVID (LC), suffering from persistent symptoms and cognitive impairment well past the acute stage. As the mechanisms of LC remain elusive, we utilized single-cell...
  8. SNT Gatchaman

    Differences in SARS-CoV-2 antigen persistence in […] systemic autoimmune rheumatic diseases compared to the general population…, 2026, Patel+

    Differences in SARS-CoV-2 antigen persistence in individuals with systemic autoimmune rheumatic diseases compared to the general population: A RECOVER-Adult Cohort Study BACKGROUND Individuals with systemic autoimmune rheumatic diseases (SARDs) are at risk for worse acute and post-acute...
  9. ME/CFS Science Blog

    ME/CFS Science Blog article - Immune findings in ME/CFS

    Link to the article: https://mecfsscience.org/immune-findings-in-me-cfs/
  10. forestglip

    Preprint Persistent SARS-CoV-2 Spike is Associated with Localized Immune Dysregulation in Long COVID Gut Biopsies, 2026, Abraham Soria et al

    Persistent SARS-CoV-2 Spike is Associated with Localized Immune Dysregulation in Long COVID Gut Biopsies [Line breaks added] Abstract SARS-CoV-2 persistence is a proposed driver of Long COVID (LC), but the in-situ relationship between residual viral antigen and immune dysregulation remains...
  11. SNT Gatchaman

    Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome…, 2026, Augustin+

    Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome: Insights from a prospective, observational, cross-sectional case-control study Post-COVID syndrome (PCS) is a complex condition that can emerge after recovery from SARS-CoV-2 infection, even in young, healthy...
  12. SNT Gatchaman

    Preprint A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002…, 2026, Peluso+

    A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002 in people with Long COVID Long COVID is a disabling chronic illness with no proven treatments. Persistence of SARS-CoV-2 has been proposed as a biological driver of the disease...
  13. SNT Gatchaman

    CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in [Covid & LC], 2026, Fanelli+

    CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in SARS-CoV-2 infection and long COVID-associated sequelae INTRODUCTION Elevated inflammation and immune dysregulation are the main consequences of severe acute respiratory syndrome...
  14. Mij

    Serum extracellular vesicle RNA profiles in long COVID: insights from exercise-induced gene modulation, 2026, Asghar Abbasi et al

    Abstract The Persistence of SARS-CoV-2 in tissues has been proposed as a driver of prolonged symptoms in long COVID. Pulmonary rehabilitation with exercise training is a well-established intervention for improving symptoms, functional capacity, and inflammation in chronic cardiorespiratory...
  15. SNT Gatchaman

    SARS-CoV-2 infection is associated with hypothalamic orexin suppression and persistent cortical NeuN attenuation, 2026, Yoon et al.

    This is the preprint. Go to post #9 for the published paper Disruption of the hypothalamic orexin system links SARS-CoV-2 infection to persistent cortical neuronal pathology Long COVID frequently presents with persistent neurological symptoms, including cognitive impairment, fatigue, and...
  16. SNT Gatchaman

    Preprint Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism, 2026, Carroll+

    Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism Infection rates involving bacterial and viral pathogens have increased precipitously after the COVID-19 pandemic. While it has been speculated that higher...
  17. forestglip

    [Abstract] Broadly neutralizing antibodies to SARS-CoV-2 in Long COVID areassociated with viral persistence and clinical outcome, 2025, Liu et al

    Broadly neutralizing antibodies to SARS-CoV-2 in Long COVID are associated with viral persistence and clinical outcome Chenyu Liu, Daniel Sanson, Serhan Soylu, Leen Moens, Isabelle Meyts, Marc Jamoulle, Johan Van Weyenbergh [Line breaks added] Abstract Long COVID (also known as post-acute...
  18. John Mac

    Review Mucosal Viruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Missing Piece of the Puzzle? 2025, Carding et al

    Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic condition without a definitive aetiology, no reliable diagnostic test, and no proven effective treatment. Despite most patients reporting a post-viral onset of illness, findings to date are conflicting...
  19. SNT Gatchaman

    A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19, 2025, Nabieva et al.

    A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19 BACKGROUND Although COVID-19 is primarily an acute disease, there are cases of persistent infection, primarily in immunocompromised patients. It is hypothesized that at least some variants...
  20. J

    No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential Sick Times (AER002)

    https://thesicktimes.org/2025/08/12/no-easy-home-runs-early-long-covid-trials-of-paxlovid-and-monoclonal-antibodies-failed-but-the-treatments-still-have-potential/
Back
Top Bottom